| 價(jià)格 | 詢價(jià) |
| 包裝 | 1盒 |
| 最小起訂量 | 1盒 |
| 發(fā)貨地 | 上海 |
| 更新日期 | 2025-11-06 |
| 中文名稱:5-Hydroxy-2'-deoxyuridine | 英文名稱:5-Hydroxy-2'-deoxyuridine |
| CAS:5168-36-5 | 品牌: 一研 |
| 保存條件: Store at -20°C | 產(chǎn)品類別: 抑制劑 |
| Cas : 5168-36-5 |
產(chǎn)品屬性:
產(chǎn)品名稱 | 規(guī)格 | CAS號 | 型號 |
5-Hydroxy-2'-deoxyuridine | 1mg | 5168-36-5 | EY-Y0163620 |
Cas No.5168-36-5
別名 N/A
化學(xué)名 N/A
分子式 C9H12N2O6

分子量 244.2
溶解度 H2O: 10 mg/mL (40.95 mM)
儲存條件 Store at -20°C
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping Condition Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
產(chǎn)品描述:
5-Hydroxy-2'-deoxyuridine (5-OHdU) is a major stable oxidation product of 2'-Deoxycytidine. 5-Hydroxy-2'-deoxyuridine can be incorporated into DNA in vitro by DNA polymerase[1].
To study the specificity of nucleotide incorporation opposite 5-hydroxypyrimidines in template DNA, 18- and 45-member oligodeoxyribonucleotides, containing an internal 2'-deoxy-5-hydroxyuridine (5-OHdU) in two different sequence contexts, were used. Translesion synthesis past 2'-deoxy-5-hydroxyuridine (5-OHdU) in both oligonucleotides occurred, but pauses both opposite, and one nucleotide prior to, the modified base in the template is observed. The specificity of nucleotide incorporation opposite 2'-deoxy-5-hydroxyuridine (5-OHdU) in the template is sequence context dependent. In one sequence context, dA is the principal nucleotide incorporated opposite 2'-deoxy-5-hydroxyuridine (5-OHdU). However in a second sequence context, dC is the predominant base incorporated opposite 2'-deoxy-5-hydroxyuridine (5-OHdU). In that same sequence context, dC is also the predominant nucleotide incorporated opposite 2'-deoxy-5-hydroxyuridine (5-OHdU)[1].
[1]. Purmal AA, et al. Major oxidative products of cytosine, 5-hydroxycytosine and 5-hydroxyuracil, exhibit sequence context-dependent mispairing in vitro. Nucleic Acids Res. 1994 Jan 11;22(1):72-8.
| 成立日期 | 2014-06-05 (13年) | 注冊資本 | 100 |
| 員工人數(shù) | 50-100人 | 年?duì)I業(yè)額 | ¥ 100萬以內(nèi) |
| 主營行業(yè) | 生化試劑,抗體,細(xì)胞培養(yǎng),分子生物學(xué),免疫安全 | 經(jīng)營模式 | 工廠,試劑 |
| 產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
|---|---|---|---|---|
| 詢價(jià) |
VIP7年
|
武漢糖智藥業(yè)有限公司
|
2026-05-12 | |
| 詢價(jià) |
VIP8年
|
陜西新研博美生物科技有限公司
|
2026-06-02 | |
| 詢價(jià) |
VIP1年
|
陜西締都醫(yī)藥有限責(zé)任公司
|
2026-04-22 | |
| 詢價(jià) |
VIP1年
|
陜西締都醫(yī)藥有限責(zé)任公司
|
2026-07-27 | |
| ¥315 |
VIP5年
|
TargetMol中國(陶術(shù)生物)
|
2026-06-29 |